Verwiel Frank
Intellia Therapeutics, Inc. · Director
Verwiel Frank is listed in filings as Director at Intellia Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 13, 2025, including sale activity. Recent filings connect the profile to Intellia Therapeutics, Inc. (NTLA). The current snapshot covers public activity from Jun 14, 2024 to Jun 13, 2025. Reported amounts are shown as $95.8K to $297.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $38k1.5k shares | SellJun 17, 2024 | $25.00 | $13.44 |